Standard BioTools CFO Jeffrey Black resigns effective Aug 31; COO Alex Kim named interim CFO

STANDARD BIOTOOLS INC.

Jeffrey Black resigns as CFO effective Aug 31, 2024 to accept opportunity at another public company; no disagreement.
Alex Kim, current COO and co-founder, appointed interim CFO starting Sep 1, 2024; permanent search underway.
Sean Mackay, former IsoPlexis CEO, named Chief Business Officer with expanded responsibilities across product management, marketing, and IR.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey Black

Senior Vice President and Chief Financial Officer

LAB · STANDARD BIOTOOLS INC.

Effective: 2024-08-31
Successor: Alex Kim
Filed: July 31, 2024, 7:59 PM ET

On July 26, 2024, Jeffrey Black resigned as the Senior Vice President and Chief Financial Officer (serving as the principal financial and accounting officer) of Standard BioTools Inc. (the “Company”), effective as of August 31, 2024.

Appointed (interim)

Alex Kim

Interim Chief Financial Officer

LAB · STANDARD BIOTOOLS INC.

Effective: 2024-09-01
Successor: Alex Kim
Filed: July 31, 2024, 7:59 PM ET

On July 30, 2024, the Company’s Board of Directors appointed Alex Kim, the Company’s Chief Operating Officer, to serve as Interim Chief Financial Officer of the Company, starting on September 1, 2024, to succeed Mr. Black while the Company searches for a permanent Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey Black resigned as Senior Vice President and Chief Financial Officer at STANDARD BIOTOOLS INC..

Action: resigned
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

On July 26, 2024, Jeffrey Black resigned as the Senior Vice President and Chief Financial Officer (serving as the principal financial and accounting officer) of Standard BioTools Inc. (the “Company”), effective as of August 31, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Alex Kim was appointed as Interim Chief Financial Officer at STANDARD BIOTOOLS INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On July 30, 2024, the Company’s Board of Directors appointed Alex Kim, the Company’s Chief Operating Officer, to serve as Interim Chief Financial Officer of the Company, starting on September 1, 2024, to succeed Mr. Black while the Company searches for a permanent Chief Financial Officer.

View on SEC.gov

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-084362

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.